Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
I've seen that with other reputable online academic articles. Dunno why but I think it's just a quirk of the speeded up publication process
Thanks for the info. both. Every day's a school day. I thought, incorrectly, they had to keep the time of the delayed trade but it seems like they have to keep the range at the time of the trade (and I realise this is still me making assumptions)
There's a nice article in today's Times by Tom Whipple 'Drug firms are racing to calm the cytokine storm'. It includes the line 'The most successful of these antibody treatments — in fact the most successful drugs in the world — have been used not for cancer but for rheumatoid arthritis' - which is where I'd hope SAR would come in (my words)
Is there a reason for including the date in the Subject heading? The date is shown alongside the post (or the word today). All this seems to do is make long subject headings (in Bold type) more prominent than other people's posts. If people then reply using the same wordy headings (which is the correct protocol) they seem to dominate the screen. If the odd negative word is slipped into the original heading this can make what is a very positive board seem downbeat. Might be a trivial point but I'm beginning to find it irritating.
I'd like to thank the many informative posters we have on SAR. At the moment there are others here who are neither positive nor informative. If you must respond to them it might help if you DON'T use the negative Subject lines they are trying to fill the board with
Looks like there's a push building towards Zak Mir's Golden Cross (I have no idea what this means other than it's a positive sign). Sareum comes in at 5:35 https://www.youtube.com/watch?v=rRLcPsIkkCk
RE Thoth's article. The scientist mentions treating symptoms of Covid 19 with drugs used to treat other conditions 'It could have been used in rheumatoid arthritis or in skin conditions and other lung inflammation conditions, we can repurpose now into this condition,'. Isn't that what SAR has targeted?